Addus HomeCare Co. (NASDAQ:ADUS) Receives $131.63 Average Target Price from Analysts

Shares of Addus HomeCare Co. (NASDAQ:ADUS) have received a consensus recommendation of “Moderate Buy” from the nine brokerages that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, seven have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $131.63.

ADUS has been the subject of several research reports. Oppenheimer lifted their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. Stephens upped their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 6th. Royal Bank of Canada reiterated an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a research report on Thursday, November 14th. Macquarie reissued an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a research note on Monday, November 4th. Finally, KeyCorp started coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They set an “overweight” rating and a $150.00 target price for the company.

Addus HomeCare Stock Down 0.0 %

Shares of ADUS stock opened at $120.72 on Friday. The firm has a market cap of $2.19 billion, a price-to-earnings ratio of 27.62, a PEG ratio of 2.11 and a beta of 1.02. The company’s 50 day moving average is $126.01 and its 200 day moving average is $124.24. Addus HomeCare has a 52-week low of $85.94 and a 52-week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. During the same period in the previous year, the company earned $1.03 earnings per share. The business’s revenue for the quarter was up 7.1% on a year-over-year basis. Analysts anticipate that Addus HomeCare will post 4.59 EPS for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In other news, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction on Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the completion of the sale, the chief executive officer now directly owns 141,897 shares of the company’s stock, valued at approximately $17,476,034.52. The trade was a 8.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 4.60% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Addus HomeCare

Several hedge funds and other institutional investors have recently bought and sold shares of ADUS. GAMMA Investing LLC raised its stake in Addus HomeCare by 33.8% during the 2nd quarter. GAMMA Investing LLC now owns 744 shares of the company’s stock worth $86,000 after acquiring an additional 188 shares in the last quarter. SG Americas Securities LLC acquired a new position in Addus HomeCare in the second quarter valued at $842,000. Chatham Capital Group Inc. increased its stake in Addus HomeCare by 1.2% in the second quarter. Chatham Capital Group Inc. now owns 21,609 shares of the company’s stock valued at $2,509,000 after purchasing an additional 265 shares during the period. Diversified Trust Co increased its stake in Addus HomeCare by 9.4% in the second quarter. Diversified Trust Co now owns 2,673 shares of the company’s stock valued at $310,000 after purchasing an additional 230 shares during the period. Finally, Ellsworth Advisors LLC purchased a new stake in shares of Addus HomeCare in the second quarter valued at about $598,000. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.